Burden of Hypoglycemia and Hyperglycemia in Insulin‐Treated Veterans Affairs Nursing Home Residents
Open Access
- 10 December 2025
- journal article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 74 (3) , 793-799
Abstract
Background: To avoid potential harms from hypoglycemia, guidelines for diabetes management in nursing home residents recommend less intensive glycemic control. However, it is unknown how often hypoglycemia and hyperglycemia co‐occur in the same resident, which may present challenges for deintensification of diabetes treatment. Methods: We conducted a cross‐sectional study of insulin‐treated Veterans Affairs nursing home residents with diabetes aged ≥ 65 years from 1/1/2016 to 9/30/2019 with a nursing home stay ≥ 7 days. Residents missing fingerstick glucose measurements during the first 7 days were excluded. We classified insulin use as basal insulin only, bolus insulin only, or a combination of basal and bolus insulin. We examined the prevalence of fingerstick‐detected hypoglycemia (< 54 mg/dL, 54–69 mg/dL) and hyperglycemia (250–299, 300–349, 350–399, ≥ 400 mg/dL) overall and stratified by type of insulin. Results: Among 12,031 insulin‐treated residents, the mean age was 74.4 years, 98% were male, and 22% were non‐White. Most residents ( n = 7176, 59.6%) were treated with a combination of basal and bolus insulin, 31.8% ( n = 3829) used bolus insulin alone and 8.5% ( n = 1026) used basal insulin alone. During the first 7 days of the nursing home stay, 5730 (48%) had hyperglycemia ≥ 250 mg/dL alone, 862 (7%) had hypoglycemia < 70 mg/dL alone, 1488 (12%) had both hyperglycemia and hypoglycemia, and 3951 (33%) had neither hypoglycemia nor hyperglycemia. Residents on a combination of basal and bolus insulin were more likely to have hyperglycemia ≥ 400 mg/dL (10.2% vs. 3.6% for bolus insulin alone and 1.6% for basal insulin alone, p < 0.001) and to have hypoglycemia < 54 mg/dL (8.4% vs. 2.9% for bolus alone vs. 5.9% for basal alone, p < 0.001). Conclusion: Nearly two‐thirds of nursing home residents with hypoglycemia also had hyperglycemia. Efforts to de‐intensify diabetes treatment in nursing homes will need to address the high burden of hyperglycemia by tailoring the timing and type of insulin to minimize hypoglycemia while also not worsening hyperglycemia.Keywords
Funding Information
- National Institutes of Health (K01AG073532)
- National Institutes of Health (K24AG066998)
This publication has 35 references indexed in Scilit:
- Excessive Burden of Hyperglycemia Along With Hypoglycemia in Long-Term Care Facilities Identified by Continuous Glucose MonitoringJournal of the American Medical Directors Association, 2025
- Clinical Practice Guideline for Diabetes Management in the Post-Acute and Long-Term Care SettingJournal of the American Medical Directors Association, 2024
- Comparative safety and cardiovascular effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists in nursing homesDiabetes, Obesity and Metabolism, 2024
- Severe hypoglycemia and falls in older adults with diabetes: The Diabetes & Aging StudyDiabetes Epidemiology and Management, 2023
- Medication Prescribing for Type 2 Diabetes in the US Long-Term Care Setting: Observational StudyJournal of the American Medical Directors Association, 2023
- Predictors, Disparities, and Facility-Level Variation: SGLT2 Inhibitor Prescription Among US Veterans With CKDAmerican Journal of Kidney Diseases, 2023
- Simplification of complex insulin therapy: a story of dogma and therapeutic resignationDiabetes Research and Clinical Practice, 2021
- Deintensification in older patients with type 2 diabetes: A systematic review of approaches, rates and outcomesDiabetes, Obesity and Metabolism, 2019
- Simplification of Insulin Regimen in Older Adults and Risk of HypoglycemiaJAMA Internal Medicine, 2016
- Potential Overtreatment of Diabetes Mellitus in Older Adults With Tight Glycemic ControlJAMA Internal Medicine, 2015